Development of an intravesial oxybutynin chloride solution: From formulation to quality control;Préparation hospitalière. Développement d'une solution de chlorhydrate d'oxybutynine pour instillation vésicle: De la formulation au contrôle qualité

Annales Pharmaceutiques Francaises

Volumn 63, Issue 2, 2005, Pages 162-166

  Fratta, A ^a   Bordenave, J ^a   Boissinot, C ^a   Le Grand, J ^a   Esquirol, C ^a   Radideau, E ^a   Benoit, G ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Intravesical instillations; Oxybutynin chloride; Packaging; Stability

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; OXYBUTYNIN; MANDELIC ACID DERIVATIVE;

ARTICLE; CATHETER; DRUG FORMULATION; DRUG PACKAGING; DRUG SYNTHESIS; FILTRATION; HUMAN; NEUROGENIC BLADDER; OSMOLALITY; QUALITY CONTROL; URINE INCONTINENCE; CHEMISTRY; DRUG STABILITY; SOLUTION AND SOLUBILITY;

CHEMISTRY, PHARMACEUTICAL; DRUG STABILITY; MANDELIC ACIDS; PARASYMPATHOLYTICS; PHARMACEUTICAL SOLUTIONS; QUALITY CONTROL;

EID: 17444374309     PISSN: 00034509     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4509(05)82267-9     Document Type: Article

References (9)

1. Kaplinski R, Greenfield S, Wan J, Fera M. Expanded follow-up of intravesical oxybutynin chloride use in children with neurogenic bladder. The Journal of Urology 1996; 156: 753-6.
2. Buyse G, Verpoorten C, Vereecken R, Casaer P. Intravesical application of a stable oxybutynin solution improves therapeutic compliance and acceptance in children with neurogenic bladder dysfunction. The Journal of Urology 1998; 160: 1084-7.
3. e édition, 2002.
4. e édition, 1998.
5. Greenfield S, Fera M. The use of intravesical oxybutynin chloride in children with neurogenic bladder. The Journal of Urology 1991; 146: 532-4.
6. Amark P, Eksborg S, Juneskans O, Bussman G, Palm C. Pharmacokinetics and effects of intravesical oxybutynin on the paediatric neurogenic bladder. British Journal of Urology 1998; 82: 859-64.
7. Amark P, Bussman G, Eksborg S. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children. European Urology 1998; 34: 148-53.
8. Weese D, Roskamp DA, Leach G, Zimmern P. Intravesical oxybutynin chloride: experience with 42 patients. Urology 1993; 41(6): 527-30.
9. Brendler C, Radebaugh L, Mohler J. Topical oxybutynin chloride for relaxation of dysfunctional bladders. The Journal of Urology 1989; 141: 1350-2.